Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K231836
    Manufacturer
    Date Cleared
    2023-10-30

    (130 days)

    Product Code
    Regulation Number
    888.3080
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The ClariVy" Cervical IBF System is indicated for intervertebral body fusion of the spine in skeletally mature patients. The device systems are designed for use with autogenous bone graft to facilitate fusion. One device may be used per intervertebral space. The implants are intended to be used with legally cleared supplemental spinal fixation cleared for the implanted level.

    The ClariVy™ Cervical IBF System is intended for use at one level in the cervical spine, from C3 to Tl, for treatment of cervical degenerate disc disease (DDD is defined as neck pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies). The ClariVy™ Cervical IBF System is to be used in patients who have six weeks of non-operative treatment.

    Device Description

    The purpose of this 510(k) submission is to introduce the ClariVy™ OsteoVy™ PEKK Cervical IBF configuration. The ClariVy™ Cervical IBF System is comprised of implants components. The implant component, the ClariVy™ Cervical IBF device, is a spacer, which inserts between vertebral bodies in the anterior column of the cervical spine. The spacer may be made of PEEK Optima LT1 or PEEK Optima LT1-HA with Tantalum markers. The ClariVy™ NanoVy™ Ti Cervical IBF components are made of PEEK Optima LT1 with CP Titanium coating. The ClariVy™ Cervical IBF and ClariVy™ NanoVy™ Ti may also include Titanium alloy bone screws to secure the device to the vertebral body. The ClariVy™ OsteoVy™ PEKK Cervical IBF is made from OXPEKK.

    AI/ML Overview

    I am sorry, but the provided text does not contain the information required to fulfill your request. The document is an FDA 510(k) clearance letter for a medical device (ClariVy™ Cervical IBF System), which focuses on the administrative aspects of regulatory clearance and comparison to predicate devices, rather than a detailed study report on acceptance criteria, device performance, or clinical trial methodology.

    Specifically, the document does not include:

    • A table of acceptance criteria and reported device performance.
    • Information on sample size, data provenance, or expert involvement for a test set.
    • Details on adjudication methods, MRMC studies, or standalone algorithm performance.
    • Information on the type of ground truth used.
    • Details regarding the training set, including its sample size or how its ground truth was established.

    The "Non-Clinical Testing" section
    {4} mentions mechanical testing according to ASTM standards, but it doesn't provide specific performance results against acceptance criteria. There's no mention of any study involving AI or human readers, or any other kind of clinical or image-based performance evaluation that would necessitate the information requested in your prompt.

    Ask a Question

    Ask a specific question about this device

    K Number
    K230414
    Manufacturer
    Date Cleared
    2023-05-12

    (85 days)

    Product Code
    Regulation Number
    888.3080
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The ClariVy™ Cervical IBF System is indicated for intervertebral body fusion of the spine in skeletally mature patients. The device systems are designed for use with autogenous bone graft to facilitate fusion. One device may be used per intervertebral space. The implants are intended to be used with legally cleared supplemental spinal fixation cleared for the implanted level.

    The ClariVy™ Cervical IBF System is intended for use at one level in the cervical spine, from C3 to T1, for treatment of cervical degenerate disc disease (DDD is defined as neck pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies). The ClariVy™ Cervical IBF System is to be used in patients who have six weeks of nonoperative treatment.

    Device Description

    The ClariVy™ Cervical IBF System is comprised of implants components. The implant component, the ClariVyTM Cervical IBF device, is a spacer, which inserts between vertebral bodies in the anterior column of the cervical spine. The spacer may be made of PEEK Optima LT1 or PEEK Optima LT1-HA with Tantalum markers. The ClariVy™ NanoVy™ Ti Cervical IBF components are made of PEEK Optima LT1 with CP Titanium coating. The ClariVyTM Cervical IBF System may also include Titanium alloy bone screws to secure the device to the vertebral body.

    AI/ML Overview

    This document is a 510(k) summary for the ClariVy™ Cervical IBF System. It is focused on demonstrating substantial equivalence to predicate devices for a medical implant, not an AI/ML device. Therefore, the questions related to AI/ML device acceptance criteria, studies, ground truth establishment, expert involvement, and reader studies are not applicable to the information provided.

    The document describes the device, its intended use, and substantial equivalence to legally marketed predicate devices primarily based on non-clinical testing of the implant's physical and mechanical properties.

    Here's the relevant information that can be extracted from the provided text, while noting the inapplicability of AI/ML specific questions:


    1. A table of acceptance criteria and the reported device performance

    Since this is a medical implant and not an AI/ML device, the "acceptance criteria" are related to mechanical and material performance standards for intervertebral body fusion devices, rather than diagnostic accuracy metrics. The document states that non-clinical testing was performed using "various ASTM Standards" at a third-party facility. However, specific acceptance criteria values (e.g., minimum compression strength, fatigue life) and reported performance values are not detailed in this summary. It only states that the tests "demonstrate that the ClariVy™ Ti Cervical IBF is as safe, as effective, and performs as well or better than a legally marketed predicate device."

    Acceptance Criteria (Implied)Reported Device Performance
    Compliance with ASTM Standards for intervertebral body fusion devices (e.g., mechanical properties, material biocompatibility, structural integrity, fatigue performance). Specific standards are not listed.Passed non-clinical testing demonstrating safety, effectiveness, and performance equivalent to or better than predicate devices. No specific quantitative performance data is provided in this summary.

    2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    This question relates to clinical or imaging study data. As this is for a medical implant and its clearance relies on non-clinical (mechanical and material) testing, the concept of a "test set" in the context of clinical/imaging data or data provenance is not applicable. The "testing" referred to is laboratory-based mechanical and material testing of the device itself.


    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    This question relates to studies involving human interpretation or clinical diagnosis. For a medical implant undergoing non-clinical testing, there is no concept of "experts establishing ground truth" in this manner. The "ground truth" for the device's performance is determined by established engineering and material science testing protocols and standards.


    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    Not applicable. This refers to clinical study result adjudication, which is not relevant for the non-clinical testing of a medical implant as described.


    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. This question concerns AI/ML diagnostic performance studies. The ClariVy™ Cervical IBF System is a physical medical implant, not an AI/ML device, and no such study was conducted or is relevant for its clearance.


    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable. This question concerns AI/ML device performance. The ClariVy™ Cervical IBF System is a physical medical implant.


    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    For the non-clinical testing described, the "ground truth" implicitly refers to the established scientific and engineering principles and standards (e.g., ASTM standards) against which the mechanical and material properties of the implant are measured. There is no biological or diagnostic "ground truth" as would be found in clinical or imaging studies.


    8. The sample size for the training set

    Not applicable. This question relates to AI/ML model training. The ClariVy™ Cervical IBF System is a physical medical implant.


    9. How the ground truth for the training set was established

    Not applicable. This question relates to AI/ML model training. The ClariVy™ Cervical IBF System is a physical medical implant.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1